nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0893	0.362	CbGeAlD
Capecitabine—DPYD—myocardium—dilated cardiomyopathy	0.0326	0.132	CbGeAlD
Capecitabine—DPYD—heart—dilated cardiomyopathy	0.0227	0.0922	CbGeAlD
Capecitabine—CDA—heart—dilated cardiomyopathy	0.0219	0.0887	CbGeAlD
Capecitabine—TYMP—cardiac ventricle—dilated cardiomyopathy	0.0201	0.0813	CbGeAlD
Capecitabine—DPYD—cardiac atrium—dilated cardiomyopathy	0.0194	0.0788	CbGeAlD
Capecitabine—TYMP—heart—dilated cardiomyopathy	0.0132	0.0534	CbGeAlD
Capecitabine—CES1—heart—dilated cardiomyopathy	0.0114	0.0461	CbGeAlD
Capecitabine—TYMP—cardiac atrium—dilated cardiomyopathy	0.0113	0.0457	CbGeAlD
Capecitabine—CYP2C9—heart—dilated cardiomyopathy	0.00493	0.02	CbGeAlD
Capecitabine—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00459	0.00609	CcSEcCtD
Capecitabine—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00451	0.00599	CcSEcCtD
Capecitabine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00451	0.00599	CcSEcCtD
Capecitabine—Otitis media—Lisinopril—dilated cardiomyopathy	0.00444	0.00589	CcSEcCtD
Capecitabine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00442	0.00587	CcSEcCtD
Capecitabine—Memory impairment—Lisinopril—dilated cardiomyopathy	0.0044	0.00585	CcSEcCtD
Capecitabine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00427	0.00566	CcSEcCtD
Capecitabine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00416	0.00553	CcSEcCtD
Capecitabine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00402	0.00534	CcSEcCtD
Capecitabine—Mental disability—Furosemide—dilated cardiomyopathy	0.004	0.00531	CcSEcCtD
Capecitabine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00393	0.00522	CcSEcCtD
Capecitabine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00391	0.00518	CcSEcCtD
Capecitabine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00388	0.00515	CcSEcCtD
Capecitabine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00386	0.00513	CcSEcCtD
Capecitabine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00384	0.0051	CcSEcCtD
Capecitabine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00383	0.00508	CcSEcCtD
Capecitabine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00381	0.00505	CcSEcCtD
Capecitabine—Polyuria—Furosemide—dilated cardiomyopathy	0.00381	0.00505	CcSEcCtD
Capecitabine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0038	0.00505	CcSEcCtD
Capecitabine—Swelling—Furosemide—dilated cardiomyopathy	0.00379	0.00503	CcSEcCtD
Capecitabine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00376	0.00499	CcSEcCtD
Capecitabine—Deafness—Furosemide—dilated cardiomyopathy	0.00374	0.00496	CcSEcCtD
Capecitabine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00374	0.00496	CcSEcCtD
Capecitabine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0037	0.00492	CcSEcCtD
Capecitabine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00356	0.00472	CcSEcCtD
Capecitabine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00354	0.0047	CcSEcCtD
Capecitabine—Thirst—Furosemide—dilated cardiomyopathy	0.00351	0.00466	CcSEcCtD
Capecitabine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.0035	0.00464	CcSEcCtD
Capecitabine—Neck pain—Lisinopril—dilated cardiomyopathy	0.0035	0.00464	CcSEcCtD
Capecitabine—Purpura—Furosemide—dilated cardiomyopathy	0.00347	0.00461	CcSEcCtD
Capecitabine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00346	0.00459	CcSEcCtD
Capecitabine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00343	0.00456	CcSEcCtD
Capecitabine—Lethargy—Furosemide—dilated cardiomyopathy	0.00341	0.00453	CcSEcCtD
Capecitabine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00336	0.00446	CcSEcCtD
Capecitabine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00336	0.00446	CcSEcCtD
Capecitabine—Malaise—Spironolactone—dilated cardiomyopathy	0.00334	0.00443	CcSEcCtD
Capecitabine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00331	0.0044	CcSEcCtD
Capecitabine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00328	0.00436	CcSEcCtD
Capecitabine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00324	0.00431	CcSEcCtD
Capecitabine—Irritability—Furosemide—dilated cardiomyopathy	0.00319	0.00424	CcSEcCtD
Capecitabine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00318	0.00422	CcSEcCtD
Capecitabine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00313	0.00416	CcSEcCtD
Capecitabine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00311	0.00413	CcSEcCtD
Capecitabine—Dehydration—Furosemide—dilated cardiomyopathy	0.00311	0.00413	CcSEcCtD
Capecitabine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00305	0.00405	CcSEcCtD
Capecitabine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00305	0.00404	CcSEcCtD
Capecitabine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00304	0.00404	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00301	0.004	CcSEcCtD
Capecitabine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00296	0.00393	CcSEcCtD
Capecitabine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00295	0.00391	CcSEcCtD
Capecitabine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00291	0.00386	CcSEcCtD
Capecitabine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0029	0.00385	CcSEcCtD
Capecitabine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00288	0.00383	CcSEcCtD
Capecitabine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00287	0.00381	CcSEcCtD
Capecitabine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00286	0.00379	CcSEcCtD
Capecitabine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00283	0.00376	CcSEcCtD
Capecitabine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00279	0.00371	CcSEcCtD
Capecitabine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00278	0.00369	CcSEcCtD
Capecitabine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00272	0.00361	CcSEcCtD
Capecitabine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00271	0.00359	CcSEcCtD
Capecitabine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00265	0.00351	CcSEcCtD
Capecitabine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00264	0.0035	CcSEcCtD
Capecitabine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00264	0.0035	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00261	0.00346	CcSEcCtD
Capecitabine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00261	0.00346	CcSEcCtD
Capecitabine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00258	0.00343	CcSEcCtD
Capecitabine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00256	0.0034	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00255	0.00339	CcSEcCtD
Capecitabine—Renal failure—Furosemide—dilated cardiomyopathy	0.00253	0.00336	CcSEcCtD
Capecitabine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00252	0.00334	CcSEcCtD
Capecitabine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00251	0.00333	CcSEcCtD
Capecitabine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00251	0.00333	CcSEcCtD
Capecitabine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00251	0.00333	CcSEcCtD
Capecitabine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00249	0.0033	CcSEcCtD
Capecitabine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00249	0.0033	CcSEcCtD
Capecitabine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00244	0.00323	CcSEcCtD
Capecitabine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00242	0.00322	CcSEcCtD
Capecitabine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.0024	0.00319	CcSEcCtD
Capecitabine—Urticaria—Spironolactone—dilated cardiomyopathy	0.0024	0.00319	CcSEcCtD
Capecitabine—Irritability—Lisinopril—dilated cardiomyopathy	0.00239	0.00318	CcSEcCtD
Capecitabine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00239	0.00317	CcSEcCtD
Capecitabine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00239	0.00317	CcSEcCtD
Capecitabine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00236	0.00313	CcSEcCtD
Capecitabine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00235	0.00312	CcSEcCtD
Capecitabine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00233	0.0031	CcSEcCtD
Capecitabine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00229	0.00304	CcSEcCtD
Capecitabine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00228	0.00303	CcSEcCtD
Capecitabine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00227	0.00301	CcSEcCtD
Capecitabine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00227	0.00301	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00226	0.003	CcSEcCtD
Capecitabine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00224	0.00298	CcSEcCtD
Capecitabine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00223	0.00296	CcSEcCtD
Capecitabine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00223	0.00295	CcSEcCtD
Capecitabine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00222	0.00295	CcSEcCtD
Capecitabine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00219	0.0029	CcSEcCtD
Capecitabine—Influenza—Lisinopril—dilated cardiomyopathy	0.00217	0.00288	CcSEcCtD
Capecitabine—Asthma—Lisinopril—dilated cardiomyopathy	0.00217	0.00288	CcSEcCtD
Capecitabine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00216	0.00287	CcSEcCtD
Capecitabine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00216	0.00286	CcSEcCtD
Capecitabine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00214	0.00284	CcSEcCtD
Capecitabine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00213	0.00283	CcSEcCtD
Capecitabine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00211	0.0028	CcSEcCtD
Capecitabine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00211	0.0028	CcSEcCtD
Capecitabine—Angiopathy—Furosemide—dilated cardiomyopathy	0.0021	0.00279	CcSEcCtD
Capecitabine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00209	0.00277	CcSEcCtD
Capecitabine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00209	0.00277	CcSEcCtD
Capecitabine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00207	0.00274	CcSEcCtD
Capecitabine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00207	0.00274	CcSEcCtD
Capecitabine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00206	0.00273	CcSEcCtD
Capecitabine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00203	0.00269	CcSEcCtD
Capecitabine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00203	0.00269	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00202	0.00268	CcSEcCtD
Capecitabine—Erythema—Furosemide—dilated cardiomyopathy	0.00201	0.00267	CcSEcCtD
Capecitabine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00201	0.00267	CcSEcCtD
Capecitabine—Dizziness—Spironolactone—dilated cardiomyopathy	0.002	0.00265	CcSEcCtD
Capecitabine—Flatulence—Furosemide—dilated cardiomyopathy	0.00198	0.00263	CcSEcCtD
Capecitabine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00198	0.00263	CcSEcCtD
Capecitabine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00197	0.00262	CcSEcCtD
Capecitabine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00197	0.00262	CcSEcCtD
Capecitabine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00196	0.0026	CcSEcCtD
Capecitabine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00196	0.0026	CcSEcCtD
Capecitabine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00194	0.00258	CcSEcCtD
Capecitabine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00194	0.00257	CcSEcCtD
Capecitabine—Depression—Lisinopril—dilated cardiomyopathy	0.00193	0.00256	CcSEcCtD
Capecitabine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00192	0.00255	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00192	0.00254	CcSEcCtD
Capecitabine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00191	0.00253	CcSEcCtD
Capecitabine—Rash—Spironolactone—dilated cardiomyopathy	0.0019	0.00253	CcSEcCtD
Capecitabine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0019	0.00253	CcSEcCtD
Capecitabine—Renal failure—Lisinopril—dilated cardiomyopathy	0.0019	0.00252	CcSEcCtD
Capecitabine—Vision blurred—Furosemide—dilated cardiomyopathy	0.0019	0.00252	CcSEcCtD
Capecitabine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0019	0.00252	CcSEcCtD
Capecitabine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0019	0.00252	CcSEcCtD
Capecitabine—Headache—Spironolactone—dilated cardiomyopathy	0.00189	0.00251	CcSEcCtD
Capecitabine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00188	0.0025	CcSEcCtD
Capecitabine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00188	0.00249	CcSEcCtD
Capecitabine—Anaemia—Furosemide—dilated cardiomyopathy	0.00186	0.00247	CcSEcCtD
Capecitabine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00184	0.00245	CcSEcCtD
Capecitabine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00183	0.00243	CcSEcCtD
Capecitabine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00182	0.00242	CcSEcCtD
Capecitabine—Vertigo—Furosemide—dilated cardiomyopathy	0.00181	0.0024	CcSEcCtD
Capecitabine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0018	0.00239	CcSEcCtD
Capecitabine—Leukopenia—Furosemide—dilated cardiomyopathy	0.0018	0.00239	CcSEcCtD
Capecitabine—Nausea—Spironolactone—dilated cardiomyopathy	0.00179	0.00238	CcSEcCtD
Capecitabine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00177	0.00235	CcSEcCtD
Capecitabine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00174	0.00231	CcSEcCtD
Capecitabine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00174	0.0023	CcSEcCtD
Capecitabine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00172	0.00229	CcSEcCtD
Capecitabine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00171	0.00228	CcSEcCtD
Capecitabine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00171	0.00227	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0017	0.00226	CcSEcCtD
Capecitabine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.0017	0.00226	CcSEcCtD
Capecitabine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00168	0.00223	CcSEcCtD
Capecitabine—Confusional state—Furosemide—dilated cardiomyopathy	0.00166	0.0022	CcSEcCtD
Capecitabine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00164	0.00218	CcSEcCtD
Capecitabine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00162	0.00215	CcSEcCtD
Capecitabine—Shock—Furosemide—dilated cardiomyopathy	0.00162	0.00215	CcSEcCtD
Capecitabine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00161	0.00214	CcSEcCtD
Capecitabine—Flushing—Lisinopril—dilated cardiomyopathy	0.00161	0.00214	CcSEcCtD
Capecitabine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00161	0.00214	CcSEcCtD
Capecitabine—Skin disorder—Furosemide—dilated cardiomyopathy	0.0016	0.00212	CcSEcCtD
Capecitabine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00159	0.00211	CcSEcCtD
Capecitabine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00157	0.00209	CcSEcCtD
Capecitabine—Anorexia—Furosemide—dilated cardiomyopathy	0.00157	0.00208	CcSEcCtD
Capecitabine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00156	0.00208	CcSEcCtD
Capecitabine—Chills—Lisinopril—dilated cardiomyopathy	0.00156	0.00207	CcSEcCtD
Capecitabine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00155	0.00206	CcSEcCtD
Capecitabine—Hypotension—Furosemide—dilated cardiomyopathy	0.00154	0.00204	CcSEcCtD
Capecitabine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00153	0.00204	CcSEcCtD
Capecitabine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00152	0.00202	CcSEcCtD
Capecitabine—Erythema—Lisinopril—dilated cardiomyopathy	0.00151	0.00201	CcSEcCtD
Capecitabine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00151	0.00201	CcSEcCtD
Capecitabine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00149	0.00198	CcSEcCtD
Capecitabine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00148	0.00196	CcSEcCtD
Capecitabine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00148	0.00196	CcSEcCtD
Capecitabine—Back pain—Lisinopril—dilated cardiomyopathy	0.00146	0.00194	CcSEcCtD
Capecitabine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00145	0.00193	CcSEcCtD
Capecitabine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00143	0.0019	CcSEcCtD
Capecitabine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00142	0.00189	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00142	0.00188	CcSEcCtD
Capecitabine—Fatigue—Furosemide—dilated cardiomyopathy	0.00142	0.00188	CcSEcCtD
Capecitabine—Tremor—Lisinopril—dilated cardiomyopathy	0.00142	0.00188	CcSEcCtD
Capecitabine—Constipation—Furosemide—dilated cardiomyopathy	0.00141	0.00187	CcSEcCtD
Capecitabine—Pain—Furosemide—dilated cardiomyopathy	0.00141	0.00187	CcSEcCtD
Capecitabine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.0014	0.00186	CcSEcCtD
Capecitabine—Anaemia—Lisinopril—dilated cardiomyopathy	0.0014	0.00185	CcSEcCtD
Capecitabine—Malaise—Lisinopril—dilated cardiomyopathy	0.00136	0.00181	CcSEcCtD
Capecitabine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00136	0.0018	CcSEcCtD
Capecitabine—Syncope—Lisinopril—dilated cardiomyopathy	0.00135	0.0018	CcSEcCtD
Capecitabine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00135	0.0018	CcSEcCtD
Capecitabine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00135	0.0018	CcSEcCtD
Capecitabine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00134	0.00178	CcSEcCtD
Capecitabine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00134	0.00177	CcSEcCtD
Capecitabine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00133	0.00176	CcSEcCtD
Capecitabine—Cough—Lisinopril—dilated cardiomyopathy	0.00132	0.00175	CcSEcCtD
Capecitabine—Urticaria—Furosemide—dilated cardiomyopathy	0.00131	0.00173	CcSEcCtD
Capecitabine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0013	0.00172	CcSEcCtD
Capecitabine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0013	0.00172	CcSEcCtD
Capecitabine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00129	0.00171	CcSEcCtD
Capecitabine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00129	0.00171	CcSEcCtD
Capecitabine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00129	0.00171	CcSEcCtD
Capecitabine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00128	0.0017	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00128	0.0017	CcSEcCtD
Capecitabine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00127	0.00169	CcSEcCtD
Capecitabine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00126	0.00167	CcSEcCtD
Capecitabine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00124	0.00165	CcSEcCtD
Capecitabine—Oedema—Lisinopril—dilated cardiomyopathy	0.00123	0.00164	CcSEcCtD
Capecitabine—Infection—Lisinopril—dilated cardiomyopathy	0.00122	0.00163	CcSEcCtD
Capecitabine—Shock—Lisinopril—dilated cardiomyopathy	0.00121	0.00161	CcSEcCtD
Capecitabine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00121	0.00161	CcSEcCtD
Capecitabine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00121	0.0016	CcSEcCtD
Capecitabine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0012	0.0016	CcSEcCtD
Capecitabine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.0012	0.00159	CcSEcCtD
Capecitabine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00119	0.00158	CcSEcCtD
Capecitabine—Asthenia—Furosemide—dilated cardiomyopathy	0.00118	0.00157	CcSEcCtD
Capecitabine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00118	0.00156	CcSEcCtD
Capecitabine—Pruritus—Furosemide—dilated cardiomyopathy	0.00116	0.00154	CcSEcCtD
Capecitabine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00115	0.00153	CcSEcCtD
Capecitabine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00112	0.00149	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00112	0.00149	CcSEcCtD
Capecitabine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00112	0.00148	CcSEcCtD
Capecitabine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00111	0.00147	CcSEcCtD
Capecitabine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0011	0.00146	CcSEcCtD
Capecitabine—Dizziness—Furosemide—dilated cardiomyopathy	0.00109	0.00144	CcSEcCtD
Capecitabine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00109	0.00144	CcSEcCtD
Capecitabine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00107	0.00142	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00106	0.00141	CcSEcCtD
Capecitabine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00106	0.00141	CcSEcCtD
Capecitabine—Constipation—Lisinopril—dilated cardiomyopathy	0.00105	0.0014	CcSEcCtD
Capecitabine—Pain—Lisinopril—dilated cardiomyopathy	0.00105	0.0014	CcSEcCtD
Capecitabine—Vomiting—Furosemide—dilated cardiomyopathy	0.00104	0.00139	CcSEcCtD
Capecitabine—Rash—Furosemide—dilated cardiomyopathy	0.00104	0.00138	CcSEcCtD
Capecitabine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00104	0.00137	CcSEcCtD
Capecitabine—Headache—Furosemide—dilated cardiomyopathy	0.00103	0.00137	CcSEcCtD
Capecitabine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00102	0.00135	CcSEcCtD
Capecitabine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00101	0.00134	CcSEcCtD
Capecitabine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00098	0.0013	CcSEcCtD
Capecitabine—Nausea—Furosemide—dilated cardiomyopathy	0.000976	0.0013	CcSEcCtD
Capecitabine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000975	0.00129	CcSEcCtD
Capecitabine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000975	0.00129	CcSEcCtD
Capecitabine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000908	0.00121	CcSEcCtD
Capecitabine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000885	0.00117	CcSEcCtD
Capecitabine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000872	0.00116	CcSEcCtD
Capecitabine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000844	0.00112	CcSEcCtD
Capecitabine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000815	0.00108	CcSEcCtD
Capecitabine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000784	0.00104	CcSEcCtD
Capecitabine—Rash—Lisinopril—dilated cardiomyopathy	0.000777	0.00103	CcSEcCtD
Capecitabine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000777	0.00103	CcSEcCtD
Capecitabine—Headache—Lisinopril—dilated cardiomyopathy	0.000772	0.00103	CcSEcCtD
Capecitabine—Nausea—Lisinopril—dilated cardiomyopathy	0.000732	0.000972	CcSEcCtD
